Future of Pharmacy

The growth of telehealth during the COVID-19 pandemic has caused health care providers to search for innovative solutions for harder to reach patient populations.

Pharmacists can play a more active role in educating patients on tools and resources available to them, enrolling patients in programs, gathering subjective and objective data.

Patient data are essential to providing coordinator care, but more data also creates heightened risks.

Prescription medications are vital to optimal patient outcomes, but they are also becoming increasingly expensive.

Four examples of patient care services that pharmacies can implement and why they can be beneficial to a pharmacy’s business model.

Patients want more out of community pharmacies in a post-pandemic culture.

Telehealth use expanded in the pharmacy during the pandemic, however, pharmacy personnel face challenges when implementing these services, beginning with regulatory requirements.

As pharmacy technicians continue to take on more responsibilities, actions must be taken to alleviate the burnout so many are facing.

The first part of a series outlining 5 crucial steps so pharmacies can enhance patient engagement and lower operational costs.

Customers are looking for ways to save money on prescriptions, but cash cards and coupons could hurt your bottom line. Here’s how to find a sustainable cash-pricing solution that works for you and your customers.

On average, patients visit their community pharmacist 12 times more often than they do their primary care provider

Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.

The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.

S. Diane Yamada, MD, president of the Society of Gynecologic Oncology (SGO), discusses the future of the pharmacist on the gynecologic oncology patient care team.

Carlie Traylor, PharmD, discussed the Community Pharmacy Fellowship from the National Community Pharmacists Association and CPESN.

Implement technology solutions, initiate clinical services, and shift to a proactive mindset, Michele Belcher says.

A patient’s ability to pay for specialty medications will continue to be an issue because drug costs are prohibitive and add barriers to accessibility.

Jamie Wilkey, PharmD, founder of PGx Consulting Confidence Academy, discussed how pharmacists are utilizing pharmacogenomics for their patients.

David Zgarrick, PhD, FAPhA, professor in the department of pharmacy and health systems sciences at Northeastern University, also addresses what the future of the pharmacy profession could look like.

Troy Trygstad, PharmD, PhD, MBA, executive director of CPESN USA, discussed how consumers' expectations are changing the future of pharmacy.

Jen Diehl, CPA, discussed some common financial concerns for independent pharmacies and where she sees the landscape heading in the future.

Pharmacy technicians are continuing to prove their worth as pharmacies shift their focus to the future, according to Jessica Langley-Loep, executive director of education and advocacy at the National Healthcareer Association.

Dan Benamoz, RPh, founder and executive chairman of PDS, and Chip Phillips, CEO, discussed their plans for the meeting and what they're focused on for the future of pharmacy.

Shreejit Nair, senior vice president and life sciences market business lead at CitiusTech, discusses some trends and predictions for health care IT this year and on into the future.

Brian Thornley, the Associate Vice President of Supply Excellence, Innovation and Digital Strategy at Merck, discusses what makes blockchain unique and what it could mean down the road for pharmacies.

Drug shortages, infrastructure and wholesaler challenges will be the backdrops of the pharmacy landscape this year.

With shifts in health care moving toward AI and automation, issues relating to how these innovations may impact patient safety continue to emerge.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses her hopes for the future of SHC’s diabetes DRIVE program and its adoption within health systems.

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.